Literature DB >> 26335770

Risk factors for pertussis hospitalizations in Australians aged 45 years and over: A population based nested case-control study.

Surendra Karki1, Peter McIntyre2, Anthony T Newall3, C Raina MacIntyre4, Emily Banks5, Bette Liu6.   

Abstract

Although studies have described factors associated with pertussis hospitalization in children, data on adult hospitalization are sparse. We examined the association between patient characteristics and hospitalization among older adults with pertussis. We conducted a nested case-control study of participants in the 45 and Up prospective cohort in New South Wales, Australia, with an incident pertussis diagnosis during 2006-2012. Cases were defined as those with a hospitalization coded as 'whooping cough' or 'non-specific respiratory disease/cough' between a week prior and 6 weeks after the diagnosis of pertussis based on laboratory tests. Controls were participants diagnosed with pertussis but not hospitalized. Among 265,287 participants, the incidence of pertussis and pertussis hospitalization was 83.9 (95% [confidence interval] CI, 78.7-89.6) and 2.9 (95% CI, 2.1-4.1)/100,000 person-years, respectively. Among 33 cases and 882 controls, factors associated with hospitalization were increasing age (compared to those 45-54 years, adjusted odds ratio [aOR] 5.4 (95% CI, 1.6-18.2) and 8.9 (95% CI, 2.3-34.7) in those aged 65-74 years and 75+ years, respectively) and smoking (ever versus never, aOR 2.37 (95% CI, 1.11-5.06)). The risk of pertussis hospitalization is substantially higher in ≥65 years old. A booster dose of diphtheria-tetanus-pertussis vaccine could be readily integrated into routine vaccination for this age group.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hospitalization; Incidence; Pertussis; Risk; Vaccine

Mesh:

Substances:

Year:  2015        PMID: 26335770     DOI: 10.1016/j.vaccine.2015.08.068

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

Review 1.  Improving vaccination rates in older adults and at-risk groups: focus on pertussis.

Authors:  Jung-Hyun Choi; Jaime Correia de Sousa; Monica Fletcher; Giovanni Gabutti; Lauriane Harrington; Michael Holden; Hyungwoo Kim; Jean-Pierre Michel; Piyali Mukherjee; Terry Nolan; Tobias Welte; Stefania Maggi
Journal:  Aging Clin Exp Res       Date:  2022-01-10       Impact factor: 3.636

2.  Establishing an expert consensus for the operational definitions of asthma-associated infectious and inflammatory multimorbidities for computational algorithms through a modified Delphi technique.

Authors:  Jungwon Yoon; Heather Billings; Chung-Il Wi; Elissa Hall; Sunghwan Sohn; Jung Hyun Kwon; Euijung Ryu; Pragya Shrestha; Hongfang Liu; Young J Juhn
Journal:  BMC Med Inform Decis Mak       Date:  2021-11-08       Impact factor: 2.796

3.  Immune age and biological age as determinants of vaccine responsiveness among elderly populations: the Human Immunomics Initiative research program.

Authors:  Jaap Goudsmit; Anita Huiberdina Johanna van den Biggelaar; Wouter Koudstaal; Albert Hofman; Wayne Chester Koff; Theodore Schenkelberg; Galit Alter; Michael Joseph Mina; Julia Wei Wu
Journal:  Eur J Epidemiol       Date:  2021-06-12       Impact factor: 8.082

4.  Pertussis in high-risk groups: an overview of the past quarter-century.

Authors:  Victoria A Jenkins; Miloje Savic; Walid Kandeil
Journal:  Hum Vaccin Immunother       Date:  2020-04-16       Impact factor: 3.452

5.  Perceptions of vaccine preventable diseases in Australian healthcare: focus on pertussis.

Authors:  Julianne Bayliss; Roshnee Randhawa; Kyu-Bin Oh; Walid Kandeil; Victoria A Jenkins; Elisa Turriani; Michael Nissen
Journal:  Hum Vaccin Immunother       Date:  2020-07-22       Impact factor: 3.452

Review 6.  Pertussis in Individuals with Co-morbidities: A Systematic Review.

Authors:  Denis Macina; Keith E Evans
Journal:  Infect Dis Ther       Date:  2021-06-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.